Identification and referral of women at risk for BRCA mutations.

被引：0
|
作者：
Bellcross, Cecelia
Hermstad, April
Tallo, Christine L.
Leonard, Chelsea
Pencea, Ioana
Stanislaw, Christine L.
Kohlmann, Wendy
机构：
[1] Emory Univ, Atlanta, GA USA
[2] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.1514
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1514
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Microarray expression profiles from carriers of BRCA1 and BRCA2 mutations.
    Brazil, LCA
    Dexter, T
    Fenwick, KI
    Ross, GM
    Weber, B
    Vivanco, M
    Ashworth, A
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S154 - S154
  • [22] Characteristics of colorectal cancer (CRC) patients with BRCA1 and BRCA2 mutations.
    Naseem, Madiha
    Xiu, Joanne
    Salem, Mohamed E.
    Goldberg, Richard M.
    Vanderwalde, Ari M.
    Grothey, Axel
    Philip, Philip Agop
    Seeber, Andreas
    Puccini, Alberto
    Tokunaga, Ryuma
    Battaglin, Francesca
    Berger, Martin D.
    Barzi, Afsaneh
    Hanna, Diana L.
    Zhang, Wu
    Hwang, Jimmy J.
    Shields, Anthony Frank
    Marshall, John
    Korn, Wolfgang Michael
    Lenz, Heinz-Josef
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [23] Evaluation of BRCA1 antibodies as a screening tool for germline BRCA1 mutations.
    Worsham, MJ
    Barnabas, N
    Raju, U
    Pals, G
    Wolman, SR
    Herrington, CS
    Zarbo, RJ
    AMERICAN JOURNAL OF PATHOLOGY, 1997, 151 (05): : ST1 - ST1
  • [24] Immunophenotypic characterization of breast cancers in carriers of BRCA1/BRCA2 mutations.
    Simon, SD
    Bacchi, CE
    Molina, AL
    Moreira-Filho, CA
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 870S - 870S
  • [25] Breast and ovarian cancer screening in women undergoing genetic counseling and genetics testing for BRCA1 and BRCA2 gene mutations.
    Kelly, KM
    Ellington, LA
    Leventhal, H
    Porter, K
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (11) : 2762S - 2762S
  • [26] Gene Profiling of Whole Blood May Identify Patients with BRCA Mutations.
    Mina, L. A.
    Gokmen-Polar, Y.
    Goswami, C.
    Storniolo, A. M.
    Li, L.
    Badve, S.
    Sledge, G. W.
    CANCER RESEARCH, 2011, 71
  • [27] Determinants in the uptake of genetic testing for BRCA1/2 mutations.
    Fowler, ES
    neese, ER
    Schwartzberg, LS
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S166 - S166
  • [28] Mutation analysis of PALB2 in high-risk and lower-risk patients negative for BRCA1 and BRCA2 mutations.
    Cummings, Shelly
    Peterson, Jenny
    Hughes, Elisha
    Kaldate, Rajesh R.
    Chen, Sonia
    Trost, Jeffrey T.
    Arnell, Christopher
    Saam, Jennifer R.
    Roa, Benjamin
    Fernandes, Priscilla H.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (27)
  • [29] Fabry disease: identification of ten novel mutations.
    Azibi, K
    Caillaud, C
    Manicom, J
    Puech, JP
    Kahn, A
    Poenaru, L
    AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) : 631 - 631
  • [30] Mutations.
    Bryant, E
    LIBRARY JOURNAL, 2001, 126 (11) : 68 - 68
12345